======= RFK ======= == Gene Information == * **Official Symbol**: RFK * **Official Name**: riboflavin kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55312|55312]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q969G6|Q969G6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RFK&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RFK|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613010|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the phosphorylation of riboflavin (vitamin B2) to form flavin-mononucleotide (FMN), hence rate-limiting enzyme in the synthesis of FAD. Essential for TNF-induced reactive oxygen species (ROS) production. Through its interaction with both TNFRSF1A and CYBA, physically and functionally couples TNFRSF1A to NADPH oxidase. TNF-activation of RFK may enhance the incorporation of FAD in NADPH oxidase, a critical step for the assembly and activation of NADPH oxidase. {ECO:0000269|PubMed:19641494}. |Flavokinase| |FMN biosynthetic process| |FMN metabolic process| |riboflavin kinase activity| |riboflavin biosynthetic process| |flavin-containing compound biosynthetic process| |positive regulation of NAD(P)H oxidase activity| |riboflavin metabolic process| |flavin-containing compound metabolic process| |water-soluble vitamin biosynthetic process| |regulation of NAD(P)H oxidase activity| |vitamin biosynthetic process| |ribonucleoside monophosphate biosynthetic process| |nucleoside monophosphate biosynthetic process| |ribonucleoside monophosphate metabolic process| |positive regulation of oxidoreductase activity| |nucleoside monophosphate metabolic process| |water-soluble vitamin metabolic process| |regulation of oxidoreductase activity| |reactive oxygen species metabolic process| |vitamin metabolic process| |coenzyme biosynthetic process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |cofactor biosynthetic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |coenzyme metabolic process| |ribonucleotide metabolic process| |ribose phosphate metabolic process| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |drug metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |small molecule biosynthetic process| |carbohydrate derivative biosynthetic process| |organophosphate metabolic process| |apoptotic process| |carbohydrate derivative metabolic process| |programmed cell death| |cell death| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |phosphorylation| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |positive regulation of molecular function| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2.04| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|-1.81| |[[:results:exp132|Metformin 40μM R03 exp132]]|-1.76| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-1.73| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.7| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.72| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|1.74| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|1.81| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.82| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.87| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.88| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|1.88| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|1.89| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.93| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.94| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.95| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.31| |[[:results:exp518|RK-33 8μM R08 exp518]]|2.36| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.41| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.43| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.67| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.93| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|3.5| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|6.24| ^Gene^Correlation^ |[[:human genes:s:slc25a19|SLC25A19]]|0.567| |[[:human genes:t:thg1l|THG1L]]|0.561| |[[:human genes:a:atxn10|ATXN10]]|0.545| |[[:human genes:a:alg1|ALG1]]|0.54| |[[:human genes:v:vezt|VEZT]]|0.53| |[[:human genes:t:tpk1|TPK1]]|0.507| |[[:human genes:a:atic|ATIC]]|0.495| |[[:human genes:f:fh|FH]]|0.493| |[[:human genes:g:gemin8|GEMIN8]]|0.493| |[[:human genes:u:uhrf1|UHRF1]]|0.492| |[[:human genes:r:rpp21|RPP21]]|0.486| |[[:human genes:t:trmt5|TRMT5]]|0.483| |[[:human genes:a:aasdhppt|AASDHPPT]]|0.48| |[[:human genes:d:ddx1|DDX1]]|0.48| |[[:human genes:d:ddx39a|DDX39A]]|0.471| |[[:human genes:p:pyroxd1|PYROXD1]]|0.464| |[[:human genes:g:gemin6|GEMIN6]]|0.464| |[[:human genes:r:rpia|RPIA]]|0.462| |[[:human genes:m:mrps33|MRPS33]]|0.458| |[[:human genes:g:gclc|GCLC]]|0.455| |[[:human genes:s:slc25a26|SLC25A26]]|0.455| |[[:human genes:p:pmm2|PMM2]]|0.454| |[[:human genes:a:adsl|ADSL]]|0.452| |[[:human genes:d:dpagt1|DPAGT1]]|0.449| |[[:human genes:t:ten1|TEN1]]|0.447| |[[:human genes:c:c15orf41|C15orf41]]|0.446| |[[:human genes:e:elp2|ELP2]]|0.441| |[[:human genes:p:ppcdc|PPCDC]]|0.44| |[[:human genes:t:ttc4|TTC4]]|0.439| |[[:human genes:d:dr1|DR1]]|0.432| |[[:human genes:t:trmt61a|TRMT61A]]|0.431| |[[:human genes:z:zrsr2|ZRSR2]]|0.428| |[[:human genes:e:elac2|ELAC2]]|0.428| |[[:human genes:d:dolk|DOLK]]|0.427| |[[:human genes:d:dld|DLD]]|0.427| |[[:human genes:z:zcrb1|ZCRB1]]|0.427| |[[:human genes:a:alg2|ALG2]]|0.426| |[[:human genes:r:rabggtb|RABGGTB]]|0.426| |[[:human genes:g:gtf3c6|GTF3C6]]|0.425| |[[:human genes:p:ppcs|PPCS]]|0.424| |[[:human genes:n:nbn|NBN]]|0.418| |[[:human genes:r:rft1|RFT1]]|0.417| |[[:human genes:c:ciao1|CIAO1]]|0.417| |[[:human genes:m:mis18a|MIS18A]]|0.415| |[[:human genes:h:hsd17b10|HSD17B10]]|0.413| |[[:human genes:r:rtcb|RTCB]]|0.412| |[[:human genes:t:triap1|TRIAP1]]|0.411| |[[:human genes:r:rnmt|RNMT]]|0.411| |[[:human genes:t:tsen54|TSEN54]]|0.411| |[[:human genes:t:tbcb|TBCB]]|0.411| |[[:human genes:t:tti1|TTI1]]|0.41| |[[:human genes:d:dars2|DARS2]]|0.409| |[[:human genes:u:uap1|UAP1]]|0.409| |[[:human genes:s:srp14|SRP14]]|0.406| |[[:human genes:t:tprkb|TPRKB]]|0.406| |[[:human genes:g:gmppb|GMPPB]]|0.406| |[[:human genes:u:uba3|UBA3]]|0.403| |[[:human genes:t:timm10|TIMM10]]|0.402| Global Fraction of Cell Lines Where Essential: 41/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|7/28| |bone|0/26| |breast|4/33| |central nervous system|0/56| |cervix|1/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|4/21| |liver|0/20| |lung|4/75| |lymphocyte|3/16| |ovary|2/26| |pancreas|3/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 169 * **Expression level (log2 read counts)**: 6.71 {{:chemogenomics:nalm6 dist.png?nolink |}}